Sanofi (SNY)
44.46
+0.10
(+0.23%)
USD |
NASDAQ |
Sep 01, 14:06
Sanofi Cash from Operations (TTM) : 14.07B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.07B |
| December 31, 2025 | 12.54B |
| June 30, 2025 | 12.17B |
| December 31, 2024 | 9.829B |
| June 30, 2024 | 8.782B |
| December 31, 2023 | 11.10B |
| June 30, 2023 | 10.34B |
| December 31, 2022 | 10.67B |
| June 30, 2022 | 10.69B |
| December 31, 2021 | 12.21B |
| June 30, 2021 | 10.13B |
| December 31, 2020 | 8.755B |
| June 30, 2020 | 9.326B |
| December 31, 2019 | 8.592B |
| June 30, 2019 | 7.837B |
| December 31, 2018 | 6.390B |
| June 30, 2018 | 8.049B |
| December 31, 2017 | 8.674B |
| June 30, 2017 | 8.840B |
| December 31, 2016 | 8.976B |
| June 30, 2016 | 8.948B |
| December 31, 2015 | 9.839B |
| June 30, 2015 | 10.21B |
| December 31, 2014 | 9.891B |
| June 30, 2014 | 10.15B |
| Date | Value |
|---|---|
| December 31, 2013 | 9.335B |
| June 30, 2013 | 7.448B |
| December 31, 2012 | 10.40B |
| June 30, 2012 | 12.98B |
| December 31, 2011 | 12.85B |
| June 30, 2011 | 12.81B |
| December 31, 2010 | 12.92B |
| June 30, 2010 | 12.12B |
| December 31, 2009 | 12.37B |
| June 30, 2009 | 12.78B |
| December 31, 2008 | 11.96B |
| June 30, 2008 | 10.96B |
| December 31, 2007 | 10.02B |
| June 30, 2007 | 8.855B |
| December 31, 2006 | 8.463B |
| June 30, 2006 | 7.039B |
| December 31, 2005 | 7.703B |
| June 30, 2005 | 8.467B |
| December 31, 2004 | 5.068B |
| June 30, 2004 | 2.723B |
| December 31, 2003 | 2.621B |
| June 30, 2003 | 2.036B |
| December 31, 2002 | 1.662B |
| June 30, 2002 | 1.384B |
| December 31, 2001 | 1.623B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| AstraZeneca PLC | 14.54B |
| GSK Plc | 10.64B |
| Johnson & Johnson | 27.61B |
| Eli Lilly & Co. | 28.08B |
| Merck & Co., Inc. | 19.97B |